 (Gut 1995; 36: 385-390) 
(2688%) compared with 110 of 517 (21.3%) in those from other families; the age and sex adjusted odds ratio (OR) was 1.76 (p=0.02). Factors influencing the prevalence of adenomas in screened individuals were evaluated. Multivariate analysis showed that independent variables significandy related to the risk of adenomas were: age (p<0-0001), sex (p=0.0002), and the number of generations (s>2 v 1) ofrelatives affected by either colorectal cancer or adenomas (p=0.0006). The latter variable was more highly predictive of the probability of finding an adenoma at colonoscopy than a family history of two generations with cancer only (p=0.056). The OR of having colorectal adenomas increased with age, by about twofold for each decade, and was twice as high in men than women, and in subjects with two or more generations relative to those with one generation affected by colorectal cancer or adenomas. Six There are approximately 20 000 deaths from colorectal cancer annually in England and Wales. The lifetime incidence for colorectal cancer has been estimated to be in 1 in 27 for both men and women in England and Wales.1
The ratio of new cases to deaths has not changed significantly in recent years, since the results of treatment for advanced disease are still poor. Thus, earlier detection probably offers the best hope for improving outcome.
Most colorectal cancers are thought to arise from adenomatous polyps.2 3 Moreover, it has been reported that their detection and removal by endoscopic screening could reduce the incidence of colorectal cancer. 4 Criteria for the selection of individuals for endoscopic surveillance very widely, but a family history of colorectal cancer has been used by other groups for selection for screening. 5 6 The importance of an inherited predisposition in colorectal cancer is a matter of some debate. Familial 19%) , from other registries (2%), members of families already ascertained (25%), and self referrals (27%). According to a protocol drawn up by Slack et al," using data from Lovett's series,9 individuals with an estimated risk of dying of colorectal cancer of 1 in 10 or greater were offered surveillance by colonoscopy on a five yearly basis from the age of 25 years, increasing to three yearly if colorectal adenomas were detected. These included people with two or more first degree relatives with colorectal cancer, or one first degree relative affected under the age of 45 years, or a family history of more than two generations affected by colorectal cancer. Some individuals, including those with a two generation family history of colorectal cancer or those from families in which extracolonic cancers had occurred in addition to a family history of colorectal cancer, and others who were excessively anxious, were offered screening even if they did not fulfil the usual screening criteria. In addition, some people were offered screening by colonoscopy when a first degree relative, usually a parent, had been screened in our clinic because of their family history of colorectal cancer, and had been found to have colorectal adenomas (that is, there was a two generation history of colorectal cancer or adenomas). Where colonoscopic surveillance was not offered, screening for faecal occult blood was arranged once a year. At total colonoscopy, all polyps detected were removed and sent for pathological examination.
We included in our study asymptomatic subjects who were offered colonoscopic screening and had neither symptoms relatable to colorectal disorders nor a previous diagnosis of colorectal neoplasia or inflammatory bowel disease. Six hundred and fifty one individuals fulfilled these criteria. Seven declined the offer of colonoscopy (compliance rate=99%), so 644 individuals were available for study. 
Results
The 644 individuals in the study were from 436 families. The age at colonoscopy ranged from 25 to 77 years (median 41 years). Two hundred and sixty five (41.1%) subjects were male; the percentage of males was similar in each age category (range 39.5-42.8%). Four hundred and fifty nine (71.3%) individuals from 355 families had relatives affected by colorectal cancer; 185 (29.7%) from 81 families had additional relatives known to have colonic adenomas.
One hundred and twenty seven (19.7%) individuals belonged to 69 families who fulfilled the Amsterdam criteria for HNPCC. A further 245 had either two or more first degree relatives affected, or a first degree relative diagnosed with colorectal cancer aged <45 years, or two or more generations affected. Of the remaining 272 subjects, 63 had only second degree relatives affected by colorectal cancer (49 had two or more second degree relatives, and 14 had a first degree relative or second degree relative with adenomas or extracolonic cancers found in the cancer family syndrome), and 209 had one first degree relative diagnosed >45 years (in 24 the first degree relative was affected before 50 years of age, 59 had two or more affected second degree relatives, 77 had one second degree relative, and 49 had a first degree relative or second degree relative with adenomas or extracolonic cancers).
PATHOLOGICAL FINDINGS
Polyps were detected in 173 (26.9%) screened subjects (Table I) . One or more adenomas were found in 144 (22.4%) subjects, and 21 of these had synchronous metaplastic polyps. Twenty nine (4.5%) patients had metaplastic polyps only.
Of 144 subjects with adenomas, seven (4.9%) had six or more adenomas (range 6-300). These multiple adenomas were more frequent in patients from Amsterdam criteria families than from other families (1 180/o and 2.7% respectively; p=0 03). One 50 year old woman with a pedigree consistent with HNPCC was found on colonoscopy to have about 300 adenomas, but there were none in the rectum. Despite this, these findings were consistent with the diagnosis of familial adenomatous polyposis. None of her affected The results of the multivariate analysis are shown in Table V . Age, sex, and all the eight family history variables were considered. The variables selected by the procedure to enter the model were (in order of entry): age (p<0.0001), sex (p=0.0002), and the number of generations in the family affected by either colorectal cancer or adenomas (p=0.0006). We also examined the interaction between the number of relatives and the number of generations affected in order to study whether the significance of the latter variable was explained by differences in the number of affected relatives. The results showed a significant increase in risk from the reference category 'only one relative affected with colorectal cancer' to 'two affected relatives in one generation' (OR=0.80), 'three affected relatives in one generation' (OR=0.40) compared with 'two affected relatives in two generations' (OR= 1.46) and ' 20 In the present series, 16 .6% of subjects under 50 years of age had adenomas, whereas Guillem found no adenomas in the individuals less than 50 years included in the control group of his study.20 In the present series, the prevalence of adenomas in the 50-59 years age group was 36%, which is about double the average estimated prevalence of adenomas in average risk individuals of the same age in the quoted studies (15%), whereas the prevalence in our subjects aged over 60 years was only slightly higher (46/2% V
35/o).
Within the screened group, the higher prevalence of adenomas with increasing age and in male subjects is consistent with the data from previous studies in patients with or without a positive family history.6 [14] [15] [16] [17] [18] [19] [20] In essence, in our series the prevalence of adenomas in men was the same as the prevalence in women a decade later. This was found to be true at all ages except the youngest (25-34 years). There was no difference between the morphological features of adenomas in men and women (Tables I and II) .
It is clear from Table I that adenomas are more common in individuals from HNPCC families, and other features such as multiple adenomas and right sided lesions are also X2 trend [14] [15] [16] [17] [18] [19] [20] (p value) ( commoner in this group. These are established characteristics of HNPCC. Interestingly, metaplastic polyps were more common in individuals without a family history conforming to HNPCC. Since screening only those with a family history of HNPCC would have detected only 23-6% of adenomas and four of the seven cancers, we set out to see whether other characteristics of the pedigree were predictive of an increased risk of adenomas in the screened subjects.
The only family history variable examined in previous published studies has been the number of relatives (first degree relatives only, or first degree relatives and second degree relatives) with colorectal cancer19 20 23 or with colorectal cancer or adenomas.6 In all four studies an increased risk of about twofold was observed in subjects with two or more v one affected relative. In the present study the most powerful family history predictor of adenoma prevalence was the number of generations (two or more v one) affected by either colorectal cancer or adenomas, irrespective of the other variables analysed: the total number of relatives or first degree relatives affected, early age onset (c50 years) of cancer in the relatives, or the presence of the Amsterdam criteria for HNPCC (Tables III and V) . In our series, people with two or more generations affected by colorectal cancer or adenomas had more relatives with colorectal cancer than those with one affected generation only (mean (SEM) number of first degree relatives or second degree relatives, or both 3 1 (0.07) and 1.6 (006) respectively, p<0001), and a greater number of first degree relatives affected by colorectal cancer or adenomas (40-2% with more than one first degree relatives in two or more generations families v 23 /8% with more than one first degree relatives in one generation families, p=0O001).
Thus the pedigree variable found to be the most significant indicator of having adenomas in this study was not totally independent of the other variables.
The results could have been biased by the fact that in 113 families more than one individual was screened and included in the analysis. When the analysis was repeated, randomly choosing one individual from each family, the number of generations affected by colorectal cancer or adenomas, or both, still emerged as the most significant variable after age and sex, with no other family history variable entering the model.
We observed an increased prevalence of adenomas in individuals from the 35 families with one affected generation represented by individuals with adenomas rather than colorectal cancer. While this might represent inheritance of an adenoma prone genotype, we cannot exclude the possibility that other factors associated with our selection process for colonoscopy (such as an increased family history of extracolonic cancers) had played a role. In nearly half (47%) of these families there was indeed a more extensive family history of extracolonic cancers. We are currently investigating this.
The choice of criteria for offering colonoscopic surveillance is a major problem in planning a screening programme, since colonoscopy is costly (about £450), and carries a small but important risk of morbidity. 24 If colonoscopic screening had been offered only to individuals from HNPCC families, the rate of detection of adenomas would have been less than if the screening criteria were widened to include two generation histories of colorectal cancer with or without adenomas. If screening were to have been offered to subjects from families with two or more generations affected by colorectal cancer or adenomas, about 80% of the total adenomas and all of the cancers (seven of seven) would have been detected (Table IV) . If surveillance by flexible sigmoidoscopy had been offered to the individuals with a lower risk, as suggested by Rozen, 6 at least 16 more subjects with adenomas would have been diagnosed, raising the overall detection rate of adenomas in our series to about 90%.
All the patients with a cancer had two or more generations of relatives affected by colorectal cancer or adenomas in their family. Only one cancer had developed beyond Dukes's stage A, suggesting that screening had probably improved the outlook for disease free survival in these patients. All 27 However, the value of this family history variable might often be limited by the fact that information about relatives with adenomas is not easily available where many members of the family are not under surveillance. In our series, most relatives (68%) with adenomas were ascertained by the screening process itself (Table IV) . If the detection of adenomas in the screened population is indicative of an increased risk of colorectal cancer and can prevent cancer deaths in the long term, it may be that screening can be focused on those groups found to have a higher risk of adenomas at colonoscopy. We have actually increased the population screened to those who do not fulfil the original criteria set out by Slack. Our novel observation of the strong predictive power of having two or more generations affected by colorectal cancer or adenomas (in addition to the original screened groups) needs to be validated in other series before any recomjmendations based on these findings can be made. 
